Evidence map›Paper›PMID 15446583›Full record

ArticleBrain pathology (Zurich, Switzerland)2004

Genetic and expression profiles of cerebellar liponeurocytomas.

Sonja Horstmann, Arie Perry, Guido Reifenberger, Felice Giangaspero, Herve Huang, Akira Hara, Jun Masuoka, Nikolai G Rainov, Markus Bergmann, Frank L Heppner and 18 more

Open access · greenAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Cerebellar liponeurocytoma: illustrative case.Journal of neurosurgery. Case lessons · 2025
    Article
  3. Review
  4. Glioneuronal and Neuronal Tumors of the Central Nervous System.Advances in experimental medicine and biology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Uncommon low-grade brain tumors.Neuro-oncology · 2019
    Review
  9. Cerebellar liponeurocytoma - a rare entity: a case report.Journal of medical case reports · 2018
    Article
  10. Cerebellar Liponeurocytoma: Relevant Clinical Cytogenetic Findings.Journal of pathology and translational medicine · 2017
    Article
  11. Article
  12. Papillary glioneuronal tumor--a rare entity: report of four cases and brief review of literature.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2012
    Review
  13. Article
  14. Article
  15. Review
  16. A recurrent cerebellar lesion in a young boy.Brain pathology (Zurich, Switzerland) · 2008
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 9 institutions in 8 countries.

Sonja HorstmannInternational Agency for Research on Cancer, Lyon, France.
Arie Perry
Guido Reifenberger
Felice Giangaspero
Herve Huang
Akira Hara
Jun Masuoka
Nikolai G Rainov
Markus Bergmann
Frank L Heppner
Sebastian Brandner
Leila Chimelli
Nádia Montagna
Thad Jackson
Daron G Davis
William R Markesbery
David W Ellison
Roy O Weller
Gian L Taddei
Renato Conti
Marc R Del Bigio
Ricardo González-Cámpora
V V Radhakrishnan
Figen Söylemezoglu
Emmanuelle Uro-Coste
Jiang Qian
Paul Kleihues
Hiroko Ohgaki
Centre International de Recherche sur le Cancer · FRHacettepe University · TRHeinrich Heine University Düsseldorf · DESree Chitra Thirunal Institute for Medical Sciences and Technology · INUniversity Hospital of Zurich · CHUniversity of Florence · ITUniversity of Manitoba · CAUniversity of Zurich · CHWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebellar liponeurocytoma, a rare, newly identified CNS neoplasm of adults, is characterized by advanced neuronal/neurocytic and focal lipomatous differentiation, low proliferative potential and a favorable clinical prognosis. Despite the different age distribution and benign biological behavior, the cerebellar liponeurocytoma shares several features with the cerebellar medulloblastoma, which may include an origin from the periventricular matrix of the fourth ventricle or the external granular layer of the cerebellum. To establish the genetic profile of cerebellar liponeurocytomas, we have formed an international consortium and collected tumor samples from 20 patients. DNA sequencing revealed TP53 missense mutations in 4 (20%) of 20 cerebellar liponeurocytomas, a frequency higher than in medulloblastomas. There was no case with PTCH, APC, or beta-catenin mutations, each of which may be present in subsets of medulloblastomas. Isochromosome 17q, a genetic hallmark of classic medulloblastomas, was not observed in any of the cases investigated by FISH analysis. cDNA array analyses were carried out on 4 cerebellar liponeurocytomas, 4 central neurocytomas, and 4 classic medulloblastomas. Cluster analysis of the cDNA expression data of 1176 genes grouped cerebellar liponeurocytomas close to central neurocytomas, but distinct from medulloblastomas. These results suggest cerebellar liponeurocytoma as a distinct tumor entity that is genetically different from medulloblastoma. Furthermore, the cDNA expression array data suggest a relationship to central neurocytomas, but the presence of TP53 mutations, which are absent in central neurocytomas, suggests that their genetic pathways are different.

Indexed as

AdultAgedCerebellar NeoplasmsDiagnosis, DifferentialDNA, NeoplasmFemaleGenes, p53HumansIn Situ Hybridization, FluorescenceLipomaMaleMedulloblastomaMiddle AgedMutationNeurocytomaOligonucleotide Array Sequence AnalysisDNA, Neoplasm

Identifiers

PMID15446583
PMCPMC8095792
OpenAlexW2011150024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.